
NYSE:BA
This summary was created by AI, based on 17 opinions in the last 12 months.
Boeing is in a recovery phase after facing significant challenges in recent years, including management issues and production delays. The company is gradually improving its performance, with increasing deliveries and a substantial order backlog. However, experts express mixed feelings about the stock's valuation and future potential. While some analysts see a turnaround, others emphasize the ongoing high debt levels and uncertainty around future earnings. Comparisons are drawn with other defense and aerospace firms, highlighting Boeing's unique challenges within the industry. Despite recent stock price increases, many experts suggest caution, indicating that while there are opportunities, significant risks remain.
Aerospace and defence have long contracts, so that's attractive. Also, you don't pay for the future as you do with pharma, because these companies keep their projects in development in secret; then they just unveil them. He likes Boeing for its civil aviation and defence sides. He prefers this over Lockheed.